2009Unpublished venueRequires access

Clinical eff icacy of montelukast associated with Seretid on asthma children

Hua Yin

Open publisher page 0 citations

Abstract

Objective To evaluate the clinical efficacy ofmontelukast on asthma children.Methods A total of 48 children with asthma were randomly divided into two groups:montelukast group(group A) and Seretid group(group B).32 children in group A were treated with montelukast and Seretid for 3 month,and 16 children in group B were treated with only Seretid for 3 month.Results There was significant amelioration concerning the clinical efficacy rates and lung function efficacy rates,respectively,without serious cases in both groups and also no statistically significant difference between them(P0.05).Conclusion Montelukast is a effective drug in treating childrenwith asthma and possesses reliable efficacy and less adverse reaction.Montelukast associated with Seretid can be used to treat asthma effectively.

About this research paper

What this paper is about

Objective To evaluate the clinical efficacy ofmontelukast on asthma children.Methods A total of 48 children with asthma were randomly divided into two groups:montelukast group(group A) and Seretid group(group B).32 children in group A were treated with montelukast and Seretid for 3 month,and 16 children in group B were treated with only Seretid for 3 month.Results There was significant amelioration concerning the clinical efficacy rates and lung function efficacy rates,respectively,without serious cases in both groups and also no statistically significant difference between them(P0.05).Conclusion Montelukast is a effective drug in treating childrenwith asthma and possesses reliable efficacy and less adverse reaction.Montelukast associated with Seretid can be used to treat asthma effectively.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the clinical efficacy ofmontelukast on asthma children.Methods A total of 48 children with asthma were randomly divided into two groups:montelukast group(group A) and Seretid group(group B).32 children in group A were treated with montelukast and Seretid for 3 month,and 16 children in group B were treated with only Seretid for 3 month.Results There was significant amelioration concerning the clinical efficacy rates and lung function efficacy rates,respectively,without serious cases in both groups and also no statistically significant difference between them(P0.05).Conclusion Montelukast is a effective drug in treating childrenwith asthma and possesses reliable efficacy and less adverse reaction.Montelukast associated with Seretid can be used to treat asthma effectively.

Key concepts: Montelukast, Medicine, Asthma, Clinical efficacy, Group B, Group A, Lung function, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical eff icacy of montelukast associated with Seretid on asthma children — Research Paper | ScholarLens